Objective to investigate the effect of Huoxue Jiedu Jiangtang Recipe (HJJR) on cardiac remodeling and function prognosis in diabetic patients complicated with coronary heart disease (CHD) after percutaneous coronary intervention (PCI), and to explore its possible mechanism. Methods 92 diabetic patients with CHD who had received PCI therapy, were equally randomized into the treatment group (46) and the control group (46) from January 2016 to August 2016. The control group were given standardized western medicine, while treatment group received HJJR besides standardized treatment. The treating course were 2 months. Before and after treatment, the left ventricular morphology index [left ventricular end diastolic diameter (LVEDD), left ventricular end systolic diameter (LVESD), left ventricular posterior wall thickness (LVPWT), left ventricular end-diastolic ventricular septal thickness (LVEST)] and the cardiac function data [stroke volume (SV), left ventricular fractional shortening (FS), the cardiac index (CI), cardiac output (CO), maximum blood flow velocity of early diastolic/ atrium late diastolic (E/A), left ventricle ejection fraction (EF)] were detected with echocardiography. The serum levels of C-reactive protein (CRP), tumor necrosis factor-a (TNF-α), interleukin-6 (IL-6) and Angiotensin II (Ang II) were tested with enzyme linked immunosorbent assay (ELISA), and the clinical efficacy and 5-year survival rate were evaluated. Results The total clinical effective rate and 5-year survival ratio in treatment group were higher than those in control group (P<0.05). Serum inflammatory mediators (CRP, IL-6, TNF-α) and Ang II decreased more than that in the control group (all P<0.05); And in treatment group, the left ventricular morphology index (LVESD, LVEDD) decreased more than that in the control group, while the cardiac function indexes (∆ FS, CO, CI, SV, LVEF, E/A) were increased more in treatment group. Conclusion HJJR can hold back the deterioration of heart restructure, improve heart function, ameliorate prognosis and prolong living in diabetic CHD after PCI, and its partial therapeutic effects might come from its reducing the level of Ang II and anti-inflammatory function.
Published in | American Journal of Biomedical and Life Sciences (Volume 9, Issue 5) |
DOI | 10.11648/j.ajbls.20210905.20 |
Page(s) | 286-291 |
Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
Copyright |
Copyright © The Author(s), 2021. Published by Science Publishing Group |
Huoxue Jiedu Jiangtang Recipe, Diabetes Mellitus, Coronary Heart Disease, Heart Remodeling, Percutaneous Coronary Intervention
[1] | Kai Yu, Liyun Ma, Yingping Wei. The Risk of Cardiovascular Events in Patients with Coronary Heart Disease Combined with Type 2 Diabetes: Meta-Analysis. Advances in Clinical Medicine. 2021, 11 (1): 125-131. |
[2] | Wan Chunling, Yang Yaru, Jiao Yahui. Clinical analysis of adverse cardiovascular events in patients with acute coronary syndrome complicated with type 2 diabetes mellitus. J Clin Psychosom Dis, 2018, 24 (4): 20-22. |
[3] | Diabetes branch of Chinese Medical Association. Guidelines for the prevention and treatment of type 2 diabetes in China. Chinese Journal of diabetes. 2018, 10 (1): 4-65. |
[4] | Fu Xianzhao, Huang Zhenfeng, Huang Wenhua, et al. Review and Prospect of the Preventive Effect of “Supplementing Qi and Nourishing Yin, Activating Blood Circulation and Detoxifying” on Diabetes Mellitus Complicated with Acute Coronary Syndrome. [J]. Chin J TCM WM Crit Care, 2017, 24 (5): 547-551. |
[5] | Fu Xianzhao*, Huang GuangMing, Qiu HaiXian, et al. Immune Regulation of "Nourishing Yin and Qi, Activating Blood Circulation and Detoxifying" in Elderly Diabetic Patients omplicated with Coronary Heart Disease. Science Journal of Public Health, 2020, 8 (6): 161-167. |
[6] | Cardiovascular branch of Chinese Medical Association, Editorial board of Chinese Journal of cardiovascular disease. 2019 Chinese Society of Cardiology (CSC) guidelines for the diagnosis and management of patients with ST-segment elevation myocardial infarction. Chin J Cardiol, 2019, 47 (10): 766-783. |
[7] | Cardiovascular branch of Chinese Medical Association, Editorial board of Chinese Journal of cardiovascular disease. Unstable angina and non-ST-elevation myocardial infarction guidelines for diagnosis and treatment. Chin J Cardiol, 2007, 35 (4): 295-304. |
[8] | Zheng Xiaoyi. the new guiding principles of Chinese medicine for clinical research. BeiJing: China Medical Science and Technology Publishing House, 2002: 68-73. |
[9] | ZHONG Qiaoqing, ZHU Lingyan, ZHANG Guogang, et al. Atherosclerotic cardiovascular disease in diabetes--mechanisms, clinical represent and management. Chinese Journal of Cardiovascular Review, 2018, 16 (12): 1069-1072. |
[10] | Shen Ying, Ding Fenghua, Lu Lin, Zhang Ruiyan, Shen Weifeng. Blood pressure management in diabetic patients with coronary artery disease. Chinese Journal of Cardiology, 2020, 1: 5-9. |
[11] | CZHANG Zengping, WANG Weijia, KONG Yina, WANG Congrui. orrelation between the stability of carotid artherosclerotic plaque and the levels of serum adopinectin and IL-8 in patients with acute cerebral infraction. J Xuzhou Med Univ 2, 2019, 39 (4): 289-292. |
[12] | Zeinalova NV, Kurbanov YZ, Mirzazade VA, Rzayeva RA, Novruzova MS. The risk of cardiovascular death in type 2 diabetes. Klin Med (Mosk), 2017, 95: 57-59. |
[13] | Gao Runlin. Advances and perspectives in coronary intervention in China. Chin J Cardiol, 2019, 47 (9): 675-679. |
[14] | Buntaine AJ, Shah B, Lorin JD, Sedlis SP. Revascularization Strategies in Patients with Diabetes Mellitus and Acute Coronary Syndrome [J]. Curr Cardiol Rep, 2016, 18 (8): 79. |
[15] | Hong tianpei, Mu yiming, Zhu, dalong. Intervention for adults with pre-diabetes: A Chinese expert consensus. Chinese Journal of Endocrinology and Metabolism, 2020, 5: 371-380. |
[16] | LU Hong-yan, WAN Min-ying, WANG Cheng. Analysis of Clinical Characteristics of Patients with Diabetes Mellitus Complicated with Coronary Heart Disease and Acute Myocardial Infarction. China &Foreign Medical Treatment, 2021, 7: 88-90. |
[17] | Michaelael TJ, Aristidis V. Diabetes and cardiovascular disease [M]. Sun FL translation. Ji Nan: Shandong science and technology press, 2008, 430-431. |
[18] | FU Xian-zhao, XU Jing, HUANG Wen-hua, et a1. Strategy of Stasis-resolving and Detoxification on Diabetic Coronary Heart Disease [J]. JETCM, 2014, 23 (11): 2024-2027. |
[19] | ZHU Yun-qing, HU Yun, MAO Xiao-ming. The research progress of immune disorders in Type 2 diabetes mellitus. Chinese Journal of Diabetes, 2015, 23 (9): 859-861. |
[20] | DANG Jingyi, HAO Qimeng, JIANG Na, et al. Relationship between serum lipoprotein (a), β2-microglobulin and tumor necrosis factor-α levels and degree of coronary artery lesion in patients with acute coronary syndrome. Chin J Arterioscler, 2020, 28 (8): 702-706. |
[21] | Wang Ying, Wang Aihua, Tian Tian. Correlation of endothelin-1, adiponectin, C-reactive protein and related metabolic indexes in type 2 diabetes mellitus with atherosclerosis. Guangdong Medical Journal, 2019, 40 (7): 1020-1024. |
APA Style
Fu Xianzhao, Jiang Xiaofeng, Chen Jiajun, Cen Qianli, Li Yuegui, et al. (2021). Double Regulation of Tonifying-Detoxifing on Elderly Diabetic Coronary Heart Disease After PCI. American Journal of Biomedical and Life Sciences, 9(5), 286-291. https://doi.org/10.11648/j.ajbls.20210905.20
ACS Style
Fu Xianzhao; Jiang Xiaofeng; Chen Jiajun; Cen Qianli; Li Yuegui, et al. Double Regulation of Tonifying-Detoxifing on Elderly Diabetic Coronary Heart Disease After PCI. Am. J. Biomed. Life Sci. 2021, 9(5), 286-291. doi: 10.11648/j.ajbls.20210905.20
AMA Style
Fu Xianzhao, Jiang Xiaofeng, Chen Jiajun, Cen Qianli, Li Yuegui, et al. Double Regulation of Tonifying-Detoxifing on Elderly Diabetic Coronary Heart Disease After PCI. Am J Biomed Life Sci. 2021;9(5):286-291. doi: 10.11648/j.ajbls.20210905.20
@article{10.11648/j.ajbls.20210905.20, author = {Fu Xianzhao and Jiang Xiaofeng and Chen Jiajun and Cen Qianli and Li Yuegui and Qiu Haixian}, title = {Double Regulation of Tonifying-Detoxifing on Elderly Diabetic Coronary Heart Disease After PCI}, journal = {American Journal of Biomedical and Life Sciences}, volume = {9}, number = {5}, pages = {286-291}, doi = {10.11648/j.ajbls.20210905.20}, url = {https://doi.org/10.11648/j.ajbls.20210905.20}, eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajbls.20210905.20}, abstract = {Objective to investigate the effect of Huoxue Jiedu Jiangtang Recipe (HJJR) on cardiac remodeling and function prognosis in diabetic patients complicated with coronary heart disease (CHD) after percutaneous coronary intervention (PCI), and to explore its possible mechanism. Methods 92 diabetic patients with CHD who had received PCI therapy, were equally randomized into the treatment group (46) and the control group (46) from January 2016 to August 2016. The control group were given standardized western medicine, while treatment group received HJJR besides standardized treatment. The treating course were 2 months. Before and after treatment, the left ventricular morphology index [left ventricular end diastolic diameter (LVEDD), left ventricular end systolic diameter (LVESD), left ventricular posterior wall thickness (LVPWT), left ventricular end-diastolic ventricular septal thickness (LVEST)] and the cardiac function data [stroke volume (SV), left ventricular fractional shortening (FS), the cardiac index (CI), cardiac output (CO), maximum blood flow velocity of early diastolic/ atrium late diastolic (E/A), left ventricle ejection fraction (EF)] were detected with echocardiography. The serum levels of C-reactive protein (CRP), tumor necrosis factor-a (TNF-α), interleukin-6 (IL-6) and Angiotensin II (Ang II) were tested with enzyme linked immunosorbent assay (ELISA), and the clinical efficacy and 5-year survival rate were evaluated. Results The total clinical effective rate and 5-year survival ratio in treatment group were higher than those in control group (PConclusion HJJR can hold back the deterioration of heart restructure, improve heart function, ameliorate prognosis and prolong living in diabetic CHD after PCI, and its partial therapeutic effects might come from its reducing the level of Ang II and anti-inflammatory function.}, year = {2021} }
TY - JOUR T1 - Double Regulation of Tonifying-Detoxifing on Elderly Diabetic Coronary Heart Disease After PCI AU - Fu Xianzhao AU - Jiang Xiaofeng AU - Chen Jiajun AU - Cen Qianli AU - Li Yuegui AU - Qiu Haixian Y1 - 2021/11/05 PY - 2021 N1 - https://doi.org/10.11648/j.ajbls.20210905.20 DO - 10.11648/j.ajbls.20210905.20 T2 - American Journal of Biomedical and Life Sciences JF - American Journal of Biomedical and Life Sciences JO - American Journal of Biomedical and Life Sciences SP - 286 EP - 291 PB - Science Publishing Group SN - 2330-880X UR - https://doi.org/10.11648/j.ajbls.20210905.20 AB - Objective to investigate the effect of Huoxue Jiedu Jiangtang Recipe (HJJR) on cardiac remodeling and function prognosis in diabetic patients complicated with coronary heart disease (CHD) after percutaneous coronary intervention (PCI), and to explore its possible mechanism. Methods 92 diabetic patients with CHD who had received PCI therapy, were equally randomized into the treatment group (46) and the control group (46) from January 2016 to August 2016. The control group were given standardized western medicine, while treatment group received HJJR besides standardized treatment. The treating course were 2 months. Before and after treatment, the left ventricular morphology index [left ventricular end diastolic diameter (LVEDD), left ventricular end systolic diameter (LVESD), left ventricular posterior wall thickness (LVPWT), left ventricular end-diastolic ventricular septal thickness (LVEST)] and the cardiac function data [stroke volume (SV), left ventricular fractional shortening (FS), the cardiac index (CI), cardiac output (CO), maximum blood flow velocity of early diastolic/ atrium late diastolic (E/A), left ventricle ejection fraction (EF)] were detected with echocardiography. The serum levels of C-reactive protein (CRP), tumor necrosis factor-a (TNF-α), interleukin-6 (IL-6) and Angiotensin II (Ang II) were tested with enzyme linked immunosorbent assay (ELISA), and the clinical efficacy and 5-year survival rate were evaluated. Results The total clinical effective rate and 5-year survival ratio in treatment group were higher than those in control group (PConclusion HJJR can hold back the deterioration of heart restructure, improve heart function, ameliorate prognosis and prolong living in diabetic CHD after PCI, and its partial therapeutic effects might come from its reducing the level of Ang II and anti-inflammatory function. VL - 9 IS - 5 ER -